Search results
Results From The WOW.Com Content Network
Quark Pharmaceuticals is a pharmaceutical company that develops RNA interference-based treatments for chronic and acute diseases. History highlights On August 1, 2021 ...
Nereus Pharmaceuticals was a pharmaceutical company focused on the development of natural products from marine microbial and other natural sources into small molecule human therapeutics. [4] The major disease area addressed by Nereus is cancer. Nereus was purchased by Triphase Research and Development in 2012. [5]
On June 13, 2018, RespireRx Pharmaceuticals Inc. entered into a letter of intent with Noramco Inc., a producer of controlled substances bulk APIs for the pharmaceutical industry, pursuant to which the parties have entered into a 90-day period, during which they will negotiate a definitive agreement regarding the RespireRx's development of ...
Somerset Pharmaceuticals (Acq 1989) Dow B. Hickam (Acq 1991) Bertek Inc (Acq 1993) UDL Laboratories (Acq 1996) Penederm Inc (Acq 1998) Matrix Laboratories (Acq 2007) Merck KGaA (Generics div.) (Acq 2007) Bioniche Pharma Holdings (Acq 2010) Pfizer Respiratory Delivery Platform (Acq 2011) Agila Specialties (Acq 2013) Abbott Laboratories (Generics ...
Merrimack Pharmaceuticals, Inc. is a pharmaceutical company based in Cambridge, Massachusetts, United States. They specialize in developing drugs for the treatment of cancer . Merrimack's first FDA -approved drug was approved in 2015; Onivyde , a liposome encapsulated version of irinotecan is used for treating pancreatic adenocarcinoma .
Jazz Pharmaceuticals plc (a merger of Jazz Pharmaceuticals, Inc. and Azur Pharma plc) is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California , United States . [ 2 ]